Mardi Dier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Madrigal Pharmaceuticals Replaces Chief Financial Officer

By Colin Kellaher Madrigal Pharmaceuticals has hired Mardi Dier to replace Alex Howarth as chief financial officer of the clinical-stage biopharmaceutical.

Alex howarthColin kellaherMadrigal pharmaceuticalsMardi dierWest conshohockenArticle normalBiotechnology servicesCancer drugsHealthcare life sciencesSpecialized drugs medicationsManagement movesCorporate industrial newsSenior level managementContent typesFactiva filtersC amp ampe executive news filter

Madrigal Pharma CFO Alex Howarth Quits, Mardi Dier Named Replacement

(RTTNews) - Madrigal Pharmaceuticals, Inc. (MDGL) Wednesday announced that its Chief Financial Officer Alex Howarth has resigned. The company has.

Alex howarthMadrigal pharmaceuticals incPortola pharmaceuticalsUltragenyx pharmaceutical incAcelyrin incChief financial officer alex howarthMardi dierUltragenyx pharmaceutical

Acelyrin (SLRN) Q2 2023 Earnings Call Transcript

SLRN earnings call for the period ending June 30, 2023.

United statesVikram purohit morgan stanleyAkash tewari jefferiesShao lee linGil labrucherieAkash tewariVikram purohitPiper sandlerPaul pelosoJohn gouTyler van burenTyler marciniakYasmeen rahimiMorgan stanleyInvestor relationsRisk factors

Ultragenyx Pharma (RARE) Announces CFO Departure

Ultragenyx Pharma (RARE) Announces CFO Departure
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Aaron olsenTed huizengaMediajeff blakeEmild kakkisExchange commissionContactsultragenyx pharmaceutical inc investorsjoshua higaExchange commission onUltragenyx pharmaceutical incBusiness developmentMardi dierChief financial officerExecutive vice presidentChief business development officerChief accounting officerSenior vice presidentCorporate strategy

Ultragenyx Pharma (RARE) Sells Portion of Future North American Royalties on Crysvita for $500M to OMERS

Ultragenyx Pharma (RARE) Sells Portion of Future North American Royalties on Crysvita for $500M to OMERS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRob missereUltragenyx pharmaceutical incDavies ward phillips vinebergLatham watkinsKyowa kirin co ltdHead of life sciencesGibson dunnNorth americaMardi dierChief financial officerManaging directorLife sciencesDavies ward phillips